MRNS marinuspharma.com Net Income

Official company branding of Marinus Pharmaceuticals, Inc. (MRNS)

Marinus Pharmaceuticals (MRNS) has delegated the production of neuro-drugs to certified CMOs in the US and Europe to minimize logistical disruptions. The company's net profit on this chart reflects revenue dynamics, where -0.14 forms the current metric. The integration of Ztalmy into epilepsy treatment protocols creates a unique medical ecosystem, while high authority among physicians confirms the biotech's pragmatic status.

Marinus Pharma (MRNS) Company Net Income: for the period 07/04/2022 - 02/22/2025

Analytical breakdowns and data insights for company Marinus Pharmaceuticals, Inc. (MRNS)

- stock value and consensus price forecast:
Market Price Marinus Pharma|MRNS - Price Target Chart
- market capitalization data:
Market Valuation Marinus Pharma|MRNS - Enterprise Value
- company book value details:
Book Value per Share Marinus Pharmaceuticals|MRNS - Company Book Value|Market Value to Book Value marinuspharma.com|MRNS - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Marinus Pharmaceuticals|MRNS - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Marinus Pharmaceuticals Inc|MRNS - Company Total Debt|Debts to Book Capitalization Marinus Pharma|MRNS - Company Long-Term Debt|Short-Term Debt Volume Marinus Pharmaceuticals|Intermediate Coverage Ratio marinuspharma.com
- earnings and market multiples details:
MRNS - Company Net Income
Summary company analysis:Marinus Pharmaceuticals
Mass-produced product of Marinus Pharma

Investors are assessing the resilience of Marinus Pharmaceuticals (MRNS) through net income dynamics, which reflect the final financial result after deducting all operating expenses and taxes. An analysis of the company's net profitability allows for a comparison of market demand with the actual efficiency of contract capacity utilization and the modernization of its own packaging lines, determining the asset's fundamental value within the current industry cycle.

Main competitors

Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|Net Income regencellbioscience.com (RGC)|Net Profit AXSM|Net Profit ACADIA Pharma (ACAD)|Company Net Income Xenon Pharmaceuticals Inc XENE|Final Profit VKTX|Supernus Pharmaceuticals - Net Profit|Net Financial Result catalystpharma.com CPRX|Denali Therapeutics Inc. (DNLI) - Company Net Income|Company Profit HRMY|Net Income BHVN|Net Profit Amylyx Corp|Company Net Income Trevi Therapeutics (TRVI)|Net Financial Result praxismedicines.com|Anavex Life Sciences Corp. - Net Income|Final Profit CBLL|PRTA - Company Net Income|Profit After Tax ALEC|ANNX: Net Profit|Omeros - Final Profit|NGNE (Neurogene) - Net Profit|Net Profit AC Immune S.A.|Company Net Income Voyager Pharma (VYGR)|NMRA (Neumora Corp) - Final Profit|Company Net Income Scilex Holding Company SCLX|TVGN - Net Income|Alpha Cognition Corp - Net Profit|CGTX - Net Profit|IKT: Net Profit|Net Income Cassava Pharma|ASRT (Assertio Holdings) - Net Profit|Company Net Income Coya COYA|Net Income VTGN (Vistagen Therapeutics)|Net Profit ovidrx.com (OVID)|Acumen Pharma - Net Income|Profit After Payment of Taxes CRVO (CervoMed Corporation)|Alterity Therapeutics Ltd - Net Profit|Net Financial Result Clene Inc. CLNN|PEPG: Net Profit|Net Income jupiterneurosciences.com|RLMD (Relmada) - Net Profit|Net Profit Annovis Bio Corporation|Company Net Income Grace Therapeutics, Inc. (GRCE)|Company Net Income AIFF (fireflyneuro.com)|Company Net Income Klotho Neurosciences KLTO|Net Financial Result NeuroSense Therapeutics Ltd (NRSN)|RVPH - Company Net Income|MetaVia Inc (MTVA) - Net Income|NeurAxis, Inc. (NRXS) - Company Net Income|Helius Medical Technologies - Final Profit|Company Net Income Passage Bio Inc.|Company Profit NEUP (Neuphoria)|Company Net Income Minerva Neurosciences Corp (NERV)|Net Financial Result Athira Pharma Corp|Company Net Income Addex Therapeutics ADXN|ALZN: Company Profit|Cyclerion - Net Profit|Company Net Income Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Net Income|Cortigent (CRGT) - Net Profit|Company Net Income Avenue Therapeutics|BCLI: Final Profit|Company Net Income Cara Therapeutics (CARA)|CHRO - Company Net Income|Company Net Income Eliem Therapeutics Inc. ELYM|ITCI - Net Income|Longboard Pharmaceuticals - Net Profit|NKGN - Net Profit|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|Sage Therapeutics Inc. - Final Profit|SNPX (Neurotrope) - Net Profit|Trevena Inc (TRVN) - Net Financial Result|Company Net Income Vigil Neuroscience (VIGL)|Anew Medical Inc. - Company Profit|Cerevel Therapeutics, Inc. - Net Income